Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
01/2004
01/01/2004US20040001887 Bioadhesive progressive hydration tablets
01/01/2004US20040001886 Hypotensive agents; cardiovascular disorders; mixture with microcrystalline cellulose, starch ethers, magnesium stearate and colloidal silica
01/01/2004US20040001885 Loratadine; wet granulation, blending
01/01/2004US20040001884 Pharmaceutical tablet coating composition
01/01/2004US20040001883 Meloxicam suppositories
01/01/2004US20040001882 Transdermal system with fentanyl
01/01/2004US20040001881 Drug in pressure sensitive adhesive; vomiting, nausea therapy; side effect reduction
01/01/2004US20040001873 Gelled delivery vehicle containing nutritional ingredients
01/01/2004US20040001872 Using polyoxyethylene glycol solutions; mixing with drug
01/01/2004US20040001871 Lapachone delivery systems, compositions and uses related thereto
01/01/2004US20040001868 Aerosol mixture of lipid crystals with propellant
01/01/2004US20040001864 Using antigens; genetic enginering; gene expression of capsid; heat resistance
01/01/2004US20040001860 Dietary supplements for enhancing the immune system
01/01/2004US20040001790 Methods for diagnosis and treatment of tumours
12/2003
12/31/2003WO2004001703A1 Promotional simulation for transdermal patch sampler
12/31/2003WO2004001664A1 Actuation indicator for a dispensing device
12/31/2003WO2004001048A1 Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation
12/31/2003WO2004001019A2 Novel nanoparticles and use thereof
12/31/2003WO2004001002A2 Novel anticholesterol compositions and method for using same
12/31/2003WO2004000918A1 Hydrous gel and production process and use of the hydrous gel
12/31/2003WO2004000854A1 Sulfur-containing phospholipid derivatives
12/31/2003WO2004000849A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
12/31/2003WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003WO2004000388A2 Promotional simulation for transdermal patch sampler
12/31/2003WO2004000384A1 Implantable or insertable medical devices for controlled delivery of a therapeutic agent
12/31/2003WO2004000382A1 Silicone blends and composites for drug delivery
12/31/2003WO2004000381A1 Implantable or insertable medical devices for controlled delivery of a therapeutic agent
12/31/2003WO2004000372A2 Disinfecting composition, cleaning tablet produced therefrom, and use thereof
12/31/2003WO2004000364A1 Preparation containing polydimethylsiloxane for nails, cartilage, bone joint, muscle and tendon disorders
12/31/2003WO2004000363A1 Process for producing sustained-release composition
12/31/2003WO2004000362A1 Process for producing block copolymer/drug composite
12/31/2003WO2004000361A1 Metastable pharmaceutical compositions
12/31/2003WO2004000360A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
12/31/2003WO2004000359A1 Topical pharmaceutical composition comprising skin penetration enhancers for the treatment of warts
12/31/2003WO2004000358A1 Transdermal drug delivery system
12/31/2003WO2004000349A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
12/31/2003WO2004000348A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
12/31/2003WO2004000344A1 Aqueous preparation containing oligopeptides and etherified cyclodextrin
12/31/2003WO2004000339A1 Honey-based skin care preparation
12/31/2003WO2004000332A1 Anticoagulant composition
12/31/2003WO2004000325A1 Prostaglandin-containing preparation composition for nasal administration
12/31/2003WO2004000323A1 Medicinal cephem compound composition for injection
12/31/2003WO2004000320A1 Water-based preparation for eye drop
12/31/2003WO2004000303A1 Method for therapeutic modality on a patient organism during the cure of parkinson's disease
12/31/2003WO2004000296A1 (2s)-2amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
12/31/2003WO2004000293A2 Use of taurine or derivatives thereof for the treatment of alopecia
12/31/2003WO2004000291A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails
12/31/2003WO2004000289A2 Preparations for the intranasal application of selected cgrp antagonists derived from amino acids and a method for their production
12/31/2003WO2004000288A1 Fluorosiloxane matrix controlled diffusion drug delivery system
12/31/2003WO2004000287A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof
12/31/2003WO2004000286A1 Microcapsules for the delayed, controlled release of perindopril
12/31/2003WO2004000284A1 Pharmaceutical compositions with improved dissolution
12/31/2003WO2004000283A1 Popping oral administration form
12/31/2003WO2004000282A1 Stable compositions of water sensitive ingredients
12/31/2003WO2004000281A1 Rapidly disintegrating tablet
12/31/2003WO2004000280A1 Pharmaceutical formulations with improved bioavailability
12/31/2003WO2004000279A1 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
12/31/2003WO2004000277A1 Resorbable delivery systems for the treatment of cancer
12/31/2003WO2004000276A1 Resorbable matrices with coatings for delivery of bioactive compounds
12/31/2003WO2004000275A1 Transdermal aerosol compositions
12/31/2003WO2004000274A1 Oral delivery of biological active agents in a nanoemulsion formulation to the human body
12/31/2003WO2004000273A1 Oral pharmaceutical forms of liquid drugs having improved bioavailability
12/31/2003WO2004000272A1 Nasal compositions comprising a mucopolysaccharide and propylene glycol
12/31/2003WO2004000270A1 Sustained-release composition, process for producing the same and preparation thereof
12/31/2003WO2004000269A1 Short duration depot formulations
12/31/2003WO2004000268A1 Topical administration of pharmacologically active bases in the treatment of warts
12/31/2003WO2004000267A1 Method for modulation of drug release from multiphase implantable or insertable medical devices and a process for manufacturing such devices
12/31/2003WO2004000266A1 Method for oral transmucosal delivery of interferon
12/31/2003WO2004000265A2 Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
12/31/2003WO2004000264A1 Drinking straw for administering active substances, vitamins, and/or nutrients
12/31/2003WO2004000263A1 Transdermal delivery rate control using amorphous pharmaceutical compositions
12/31/2003WO2004000262A1 Process for producing solid bath additive containing shape-retaining matter and humidifying/cooling apparatus
12/31/2003WO2004000253A1 Improved pharmaceutical dental formulations
12/31/2003WO2004000235A2 Breath freshening and oral cleansing product with magnolia bark extract
12/31/2003WO2004000234A2 Breath freshening and oral cleansing product with cinnamaldehyde
12/31/2003WO2004000226A2 Liposomes containing biologically active compounds
12/31/2003WO2004000223A2 Rapidly disintegrating formulations for treating or preventing mucositis
12/31/2003WO2004000219A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
12/31/2003WO2004000211A2 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
12/31/2003WO2004000201A1 Process for producing aspheric seamless capsule and apparatus therefor
12/31/2003WO2004000197A2 Quick dissolve compositions and tablets based thereon
12/31/2003WO2004000034A2 Anthelmintic oral homogeneous veterinary pastes
12/31/2003WO2004000025A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
12/31/2003WO2004000003A2 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process
12/31/2003WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
12/31/2003WO2003082372A3 Chemiluminescent treatment of acne
12/31/2003WO2003080021A3 Formulation comprising buprenorphine
12/31/2003WO2003075839A3 Methods of inducing terminal differentiation
12/31/2003WO2003070178A3 Throat spray
12/31/2003WO2003066130A3 Transdermal drug delivery systems
12/31/2003WO2003065392A3 Photovoltaic cell interconnection
12/31/2003WO2003064607A3 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
12/31/2003WO2003061742A3 Humidity-tight cartridge for a powder inhaler
12/31/2003WO2003061728A3 Oral administration of interferon-tau
12/31/2003WO2003061621A3 Dermal application system for aminolevulinic acid-derivatives
12/31/2003WO2003059937A3 Synthetic ion channels
12/31/2003WO2003059288A3 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
12/31/2003WO2003059284A3 Composition and method for inhibiting hypersensitivity
12/31/2003WO2003059279A3 Efficient liposomal encapsulation under mild conditions
12/31/2003WO2003053413A3 Sustained-release compositions
1 ... 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 ... 2991